Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer

Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
information fournie par Boursorama CP03/12/2020 à 18:00

Strasbourg, France, December 3, 2020, 06:00 pm CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board, at its meeting today, approved the appointment of Hedi Ben Brahim as the Company's new Chairman and CEO, effective January 1st, 2021. Hedi Ben Brahim, who has been a member of Transgene's Board since May 2019, will replace Philippe Archinard. Philippe Archinard has led the company since 2005 and will remain a member of the Board of Transgene.

.../...

Valeurs associées

Euronext Paris -0.35%

0 commentaire

Signaler le commentaire

Fermer

Mes listes

Cette liste ne contient aucune valeur.